ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 906,40
0,66%
Dow Jones
44 550,32
0,29%
DAX
21 505,70
0,47%
Brent Oil
75,845
0,64%
Bitcoin
98 918,01
-2,47%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. GoodRx Holdings Inc (GDRX)

  7. GoodRx Holdings Inc (GDRX) Actualités

GDRX

GoodRx (GDRX)

GoodRx Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GDRX
DateHeureSourceTitreSymboleSociété
30/01/202522h05Business WireGoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference CallNASDAQ:GDRXGoodRx Holdings Inc
22/01/202523h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GDRXGoodRx Holdings Inc
22/01/202523h00Business WireScott Wagner Joins GoodRx Board of DirectorsNASDAQ:GDRXGoodRx Holdings Inc
15/01/202523h56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GDRXGoodRx Holdings Inc
10/01/202517h00Business WireGoodRx Offering Free Telehealth Appointments to Los Angeles Residents Affected by WildfiresNASDAQ:GDRXGoodRx Holdings Inc
09/01/202500h42Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GDRXGoodRx Holdings Inc
18/12/202422h22Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:GDRXGoodRx Holdings Inc
18/12/202422h05Business WireGoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:GDRXGoodRx Holdings Inc
17/12/202415h00Business WireGoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. CountiesNASDAQ:GDRXGoodRx Holdings Inc
16/12/202422h05Business WireGoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive OfficerNASDAQ:GDRXGoodRx Holdings Inc
05/12/202415h00Business WireGoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still SurgedNASDAQ:GDRXGoodRx Holdings Inc
13/11/202418h38PR Newswire (US)Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law FirmNASDAQ:GDRXGoodRx Holdings Inc
07/11/202420h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GDRXGoodRx Holdings Inc
07/11/202412h05Business WireGoodRx Reports Third Quarter 2024 ResultsNASDAQ:GDRXGoodRx Holdings Inc
04/11/202422h05Business WireGoodRx to Participate in Upcoming Investor ConferencesNASDAQ:GDRXGoodRx Holdings Inc
31/10/202414h00Business WireGoodRx Unveils New E-commerce Platform, Launches with Opill®NASDAQ:GDRXGoodRx Holdings Inc
29/10/202414h00Business WireGoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for AdultsNASDAQ:GDRXGoodRx Holdings Inc
28/10/202413h00Business WireRonald E. Bruehlman Joins GoodRx Board of DirectorsNASDAQ:GDRXGoodRx Holdings Inc
23/10/202415h00Business WireGoodRx Announces New Affordability Programs for Menopause Hormone TherapiesNASDAQ:GDRXGoodRx Holdings Inc
16/10/202415h00Business WireGoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to ConsumersNASDAQ:GDRXGoodRx Holdings Inc
10/10/202423h41Business WireGoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference CallNASDAQ:GDRXGoodRx Holdings Inc
26/09/202415h00Business WireGoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray)NASDAQ:GDRXGoodRx Holdings Inc
03/09/202422h43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:GDRXGoodRx Holdings Inc
08/08/202412h05Business WireGoodRx Reports Second Quarter 2024 ResultsNASDAQ:GDRXGoodRx Holdings Inc
18/07/202412h00PR Newswire (US)Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira®NASDAQ:GDRXGoodRx Holdings Inc
11/07/202415h00Business WireGoodRx Announces Date for Second Quarter 2024 Earnings Release and Conference CallNASDAQ:GDRXGoodRx Holdings Inc
10/07/202415h00Business WireIan T. Clark Joins GoodRx Board of DirectorsNASDAQ:GDRXGoodRx Holdings Inc
26/06/202415h00Business WireGoodRx Launches New “Prescription Cost Tracker” to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S.NASDAQ:GDRXGoodRx Holdings Inc
20/06/202411h45PR Newswire (US)GoodRx Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before June 21, 2024 to Discuss Your Rights - GDRXNASDAQ:GDRXGoodRx Holdings Inc
17/06/202411h45PR Newswire (US)The Gross Law Firm Reminds GoodRx Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 21, 2024 - GDRXNASDAQ:GDRXGoodRx Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:GDRX

Dernières Valeurs Consultées

COIN
ADAUSD
Cardano
COIN
ETHUSD
Ethereum
EU
CS
Axa
EU
BN
Danone
COIN
DOGEUSD
Dogecoin
EU
DG
Vinci
NYSE
MRK
Merck
EU
PX4
SBF 120
NYSE
MCD
McDonalds
COIN
XRPUSD
Ripple
EU
BNP
BNP Paribas
EU
GLE
Societe Generale
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces